Evidence map›Paper›PMID 41942457›Full record

ArticleNature communications2026

VPS26A retromer complex and SNX27 mediate stress-induced Golgi bypass of membrane proteins.

Ye Jin Kim, Chaeyoung Lee, Soo Kyung Seo, Jae Won Roh, Hye Ryung Lee, Su Jin Hwang, Nienping Chang, Hee Seong Choi, Dong Hoon Shin, Hui Kwon Kim and 6 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ye Jin Kim *Department of Pharmacology, Brain Korea 21 Project for Medical Science, Woo Choo Lee Institute for Precision Drug Development, Yonsei University College of Medicine, Seoul, Republic of Korea.ORCID http://orcid.org/0009-0008-5168-2749
Chaeyoung Lee *Department of Pharmacology, Brain Korea 21 Project for Medical Science, Woo Choo Lee Institute for Precision Drug Development, Yonsei University College of Medicine, Seoul, Republic of Korea.ORCID http://orcid.org/0009-0001-2723-9965
Soo Kyung SeoDepartment of Pharmacology, Brain Korea 21 Project for Medical Science, Woo Choo Lee Institute for Precision Drug Development, Yonsei University College of Medicine, Seoul, Republic of Korea.ORCID http://orcid.org/0009-0005-2347-0720
Jae Won RohDepartment of Pharmacology, Brain Korea 21 Project for Medical Science, Woo Choo Lee Institute for Precision Drug Development, Yonsei University College of Medicine, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0002-3692-1739
Hye Ryung LeeDepartment of Pharmacology, Brain Korea 21 Project for Medical Science, Woo Choo Lee Institute for Precision Drug Development, Yonsei University College of Medicine, Seoul, Republic of Korea.
Su Jin HwangDepartment of Microbiology and Immunology, Institute for Immunology and Immunological Diseases, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0001-9182-8281
Nienping ChangDepartment of Systems Biology and Division of Life Sciences, Yonsei University, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0002-8584-6413
Hee Seong ChoiDepartment of Systems Biology and Division of Life Sciences, Yonsei University, Seoul, Republic of Korea.ORCID http://orcid.org/0009-0002-3457-2800
Dong Hoon ShinDepartment of Pharmacology, Brain Korea 21 Project for Medical Science, Woo Choo Lee Institute for Precision Drug Development, Yonsei University College of Medicine, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0002-5574-7975
Hui Kwon KimDepartment of Integrative Biotechnology, Sungkyunkwan University, Suwon, Republic of Korea.ORCID http://orcid.org/0000-0003-0694-9244
Han Sang KimDivision of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0002-6504-9927
Hyun-Soo ChoDepartment of Systems Biology and Division of Life Sciences, Yonsei University, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0003-4067-4715
Jae Myun LeeDepartment of Microbiology and Immunology, Institute for Immunology and Immunological Diseases, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0002-5273-3113
Heon Yung GeeDepartment of Pharmacology, Brain Korea 21 Project for Medical Science, Woo Choo Lee Institute for Precision Drug Development, Yonsei University College of Medicine, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0002-8741-6177
Min Goo LeeDepartment of Pharmacology, Brain Korea 21 Project for Medical Science, Woo Choo Lee Institute for Precision Drug Development, Yonsei University College of Medicine, Seoul, Republic of Korea. mlee@yuhs.ac.ORCID http://orcid.org/0000-0001-7436-012X
Shin Hye NohDepartment of Pharmacology, Brain Korea 21 Project for Medical Science, Woo Choo Lee Institute for Precision Drug Development, Yonsei University College of Medicine, Seoul, Republic of Korea. alley282@yuhs.ac.ORCID http://orcid.org/0000-0003-3118-9240

Funding

Korea Health Industry Development Institute (KHIDI) RS-2024-00404555National Research Foundation of Korea (NRF) 2021R1I1A1A01049255National Research Foundation of Korea (NRF) 2022R1A4A1031336National Research Foundation of Korea (NRF) RS-2022-NR067483National Research Foundation of Korea (NRF) RS-2024-00351254National Research Foundation of Korea (NRF) RS-2025-18362970
6 · The paper itself

Abstract

Many proteins can reach the cell surface through a Golgi-independent unconventional protein secretion (UPS) pathway, particularly under cellular stress conditions. However, the molecular mechanisms that mediate UPS remain largely elusive. In this study, VPS26A-containing retromer complex, along with the sorting nexin SNX27, is identified as a regulator of UPS of transmembrane proteins, including the trafficking-deficient ∆F508 mutant CFTR, which causes cystic fibrosis, and the SARS-CoV-2 spike protein, associated with COVID-19. A targeted CRISPR knockout screen identified VPS26A as a key contributor in the UPS of ∆F508-CFTR. Subsequent molecular analyses revealed that SNX27 recruits ∆F508-CFTR to the VPS26A-VPS35-VPS29 retromer complex, facilitating its transport to the cell surface under UPS-inducing conditions. Additionally, VPS26A and SNX27 are necessary for UPS of the spike protein, enabling the formation of intact SARS-CoV-2 virions. These findings suggest that the retromer complex and SNX27, known for their roles in recycling endosomes, mediate previously unrecognized functions in the UPS of transmembrane proteins.

Indexed as

Golgi ApparatusMembrane ProteinsSorting NexinsVesicular Transport ProteinsCOVID-19Cystic Fibrosis Transmembrane Conductance RegulatorHEK293 CellsHeLa CellsHumansProtein TransportSARS-CoV-2Secretory PathwayStress, PhysiologicalCystic Fibrosis Transmembrane Conductance RegulatorMembrane ProteinsSNX27 protein, humanSorting NexinsVesicular Transport ProteinsVPS26A protein, humanVPS35 protein, human

Identifiers

PMID41942457
PMCPMC13230525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.